Innovation moves fast — and so do we.
We are turning bioactive RNAs into a new generation of functional ingredients for wellness, nutrition, and beauty.
Here’s how we’ve moved the needle in recent months:
🔬 The Science
- Peer-Reviewed Validation: We published our latest findings in Non-Coding RNA, further strengthening the scientific foundations behind our work.
- Platform Evolution: Our bioinformatics platform has transitioned into an agent-based system, accelerating our R&D.
- Category Reinforcement: Kresko was recognized among the world’s top 8 most innovative ingredient startups, included in the Longevity 100 – Beauty & Wellness 2025, and invited to contribute to the scientific conversation on bioactive RNAs and the gut–brain axis.
💼 The Business Case: The Hero Product of 2030
The industry signal is clear: the search for the next breakthrough ingredient is on. We are seeing growing inbound interest and strategic conversations moving into the mutual NDA stage.
We believe bioactive RNAs are emerging as one of the most promising answers.
Strategic Reinforcement: We recently welcomed Tim Carroll to Kresko’s Advisory Board. With over 20 years of experience developing and scaling functional ingredients globally, including leadership at Fonterra.
🌍 Global Momentum & Recognition
- Deep Tech Pioneer: Kresko was named a Hello Tomorrow Deep Tech Pioneer 2026.
- Award-Winning Innovation: Top 10 Finalist in the Global Food Tech Awards 2026 and featured in the FoodTech 500 for the fourth consecutive year.
- Global Footprint: Expansion through Parallel18, Scale2Miami winner, and Singapore’s BIG incubation program.
💰 Investor Note
Kresko is currently raising $500K to support its next phase of growth. With 40% of the round already committed by strategic investors, we are now in conversations to complete the raise.
We are helping bring bioactive RNAs from frontier science into the mainstream of wellness.
We’d love for you to be part of the shift!